Finance

Lists
EWL:ETR
Edwards Lifesciences Corp
€ ७४.५०
+१.१४%
(+०.८४) 1D
अक्टोबर ९, १७:३५:३७ GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for EWL...
Open
€ ७४.५८
High
€ ७५.१४
Low
€ ७४.५०
Mkt. cap
४९.१२ अरब
Avg. vol.
६१.००
Volume
०.००
52-wk high
€ ८४.००
52-wk low
€ ६२.००
No. of employees
१६ हजार
Open
€ ७४.५८
High
€ ७५.१४
Low
€ ७४.५०
Mkt. cap
४९.१२ अरब
Avg. vol.
६१.००
Volume
०.००
52-wk high
€ ८४.००
52-wk low
€ ६२.००
No. of employees
१६ हजार
News stories
From web sources and news partners
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees१६ हजार
Founded१९५८
Headquartersइरविन, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.५५ अरब
१.५७ अरब
१.६५ अरब
१.७४ अरब
Cost of goods sold
३४.५२ करोड
३४.३० करोड
३६.२६ करोड
३९.२४ करोड
Cost of revenue
३४.५२ करोड
३४.३० करोड
३६.२६ करोड
३९.२४ करोड
Research and development expenses
२८.०७ करोड
२६.७७ करोड
२६.३३ करोड
२७.८९ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५१.४६ करोड
६०.१२ करोड
५२.२२ करोड
५६.१२ करोड
Operating expense
७८.२८ करोड
८५.४६ करोड
७७.१३ करोड
८२.९१ करोड
Total operating expenses
१.१३ अरब
१.२० अरब
१.१३ अरब
१.२२ अरब
Operating income
४२.५१ करोड
३७.२० करोड
५१.४७ करोड
५१.९५ करोड
Other non operating income
११.०० लाख
२३.०० लाख
६.९९ करोड
-२.५० करोड
EBT including unusual items
३४.८४ करोड
९.०४ करोड
४५.९० करोड
५१.९८ करोड
EBT excluding unusual items
४४.४५ करोड
४६.४० करोड
६०.३६ करोड
५१.११ करोड
Income tax expense
५.६१ करोड
२.६२ करोड
७.८३ करोड
२७.८४ करोड
Effective tax rate
१६.१०%
२८.९८%
१७.०६%
५३.५६%
Other operating expenses
-१.२५ करोड
-१.४३ करोड
-१.४२ करोड
-१.१० करोड
Net income
२९.११ करोड
९.१२ करोड
३८.०७ करोड
२४.१९ करोड
Net profit margin
१८.७४%
५.८१%
२३.०९%
१३.८९%
Earnings per share
०.६७
०.५८
०.७८
०.७८
Interest and investment income
१.६७ करोड
११.४२ करोड
१.७४ करोड
१.५० करोड
Interest expense
-
-२.०४ करोड
-
-
Net interest expenses
१.६७ करोड
९.३८ करोड
१.७४ करोड
१.५० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
४६.४३ करोड
४१.४७ करोड
५५.५६ करोड
५६.२२ करोड
Gain or loss from assets sale
-
-३.३९ करोड
-
-
AI content may include mistakes. Learn more
Google एपहरू